Advanced search
Publication Cover
Current Eye Research Volume 35, 2010 - Issue 12
Submit an article Journal homepage
134
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Systemic Monoclonal Antibody Therapy (Daclizumab) in the Treatment of Cicatrizing Conjunctivitis in Stevens-Johnson Syndrome, Refractory to Conventional Therapy

Vanessa M. B. FiorelliCorrespondence[email protected]
,
Paulo E. C. DantasCorneal and External Disease Outpatient’s Clinic, Department of Ophthalmology, Santa Casa de São Paulo, Brazil
,
Allen T. JacksonFlorida Eye Research and Surgical Therapy Institute (FERST Eye Institute), Daytona Beach, Florida, USA
&
M. Cristina Nishiwaki-DantasCorneal and External Disease Outpatient’s Clinic, Department of Ophthalmology, Santa Casa de São Paulo, Brazil
Pages 1057-1062 | Received 15 Aug 2009, Accepted 21 Jul 2010, Published online: 07 Oct 2010

REFERENCES

  • Foster CS, Fong LP, Azar D, et al. Episodic conjunctivae inflammation after Stevens-Johnson syndrome. Ophthalmology. 1988;95:453–462.
  • de Rojas MV, Dart JKG, Saw VPJ. The natural history of Stevens-Johnson syndrome: Patterns of chronic ocular disease and the role of systemic immunossupressive therapy. Br J Ophthalmol. 2007;91:1048–1053.
  • Tseng SCG. Regulating of limbic epithelial stem cells. In: Nishida T (Ed.). Corneal Healing Responses to Injuries and Refractive Surgeries. The Hague: Kugler Publications, 1998; pp. 234–242.
  • Foster CS, Wilson LA, Ekins MB. Immunosuppressive therapy for progressive ocular cicatricial pemphigoid. Ophthalmology. 1982;89:340–353.
  • Jabs DA, Rosenbaum JT, Foster CS. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: Recommendations of an expert panel. Am J Ophthalmol. 2000;130:492–513.
  • Foster CS, Vitale AT. Immunosuppressive chemotherapy. In: Foster CS, Vitale AT (Eds.). Diagnosis and Treatment of Uveitis. Philadelphia: WB Saunders, 2002; pp. 177–214.
  • Papaliodis GN, Chu D, Foster CS. Treatment of ocular inflammatory disorders with Daclizumab. Ophthalmology. 2003;110:786–789.
  • Goebel J, Stevens E, Forrest K, et al. Daclizumab (Zenapax) inhibits early interleukin-2 receptor signal transduction events. Transpl Immunol. 2001;8:153–159.
  • Nussenblat RB, Peterson JS, Foster CS, et al. Initial evaluation of subcutaneous Daclizumab treatments for noninfectious uveitis. Ophthalmology. 2005;112:764–770.
  • Wohlrab J, Fisher M, Taube KM, et al. Treatment of recalcitrant psoriasis with daclizumab (letter). Br J Dermatol. 2001;144:209–210.
  • Nussenblat RB, Fortin E, Schiffman R, et al. Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: A phase I/II clinical trial. Proc Natl Acad Sci. 1999;96:7462–7466.
  • Akpek EK, Ilhan-Sarac O. Cicatrizing conjunctivitis. In: Foster CS, Azar DT, Dohlman CH (Eds.). Smolin and Thoft’s the Cornea: Scientific Foundations and Clinical Practice. Philadelphia: Lippincott Williams & Williams, 2004; 477–502.
  • Eiferman RA, Carothers DJ, Yankeelov JA Jr. Peripheral rheumatoid ulceration and evidence for conjunctival collagenase production. Am J Ophthalmol. 1979;87:703.
  • Kim EC, Foster CS. Immunomodulatory therapy for the treatment of ocular inflammatory disease: Evidence-based medicine recommendations for use. Int Ophthalmol Clin. 2006;46:141–164.
  • Sobrin L, Kim EC, Cristen W, et al. Infliximab therapy for the treatment of refractory ocular inflammatory disease. Arch Ophthalmol. 2007;125:895–900.
  • Swiatecka-Urban A. Anti-interleukin-2 receptor antibodies for the prevention of rejection in pediatric renal transplant patients: Current status. Paediatr Drugs. 2003;5:699–716.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.